Solid Biosciences Inc. SLDB Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s other income, net (note 6)?
- Solid Biosciences Inc. (SLDB) reported other income, net (note 6) of $157K in Q1 2026.
- How has Solid Biosciences Inc.'s other income, net (note 6) changed year-over-year?
- Solid Biosciences Inc.'s other income, net (note 6) decreased by 16.5% year-over-year, from $188K to $157K.
- What is the long-term trend for Solid Biosciences Inc.'s other income, net (note 6)?
- Over 3 years (2022 to 2025), Solid Biosciences Inc.'s other income, net (note 6) has grown at a 29.3% compound annual growth rate (CAGR), from -$381K to $824K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.